Efficacy and safety of voriconazole in immunocompromised patients: systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of voriconazole in immunocompromised patients: systematic review and meta-analysis

Published:2017-12-20 Issue:7 Volume:50 Page:489-494
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Rosanova Maria Teresa¹,Bes David²,Serrano Aguilar Pedro³,Sberna Norma¹,Lede Roberto⁴

Affiliation:

1. Hospital de Pediatría J. P. Garrahan, CABA, Buenos Aires, Argentina;

2. Hospital J. P. Garrahan, CABA, Buenos Aires, Argentina;

3. Servicio de Evaluación del Servicio Canario de la Salud (SESCS), Red de investigación de servicios de salud en enfermedades crónicas (REDISSEC), Tenerife, Spain;

4. Universidad Abierta Interamericana (UAI), CABA, Buenos Aires, Argentina

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2017.1418531

Reference17 articles.

1. Voriconazole: A New Triazole Antifungal Agent

2. Deoxycholate Amphotericin B and Nephrotoxicity in the Pediatric Setting

3. Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients

4. Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies

5. Voriconazole Pharmacokinetics and Safety in Immunocompromised Children Compared to Adult Patients

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic implementation for CYP2C19 and pharmacokinetics of voriconazole in children with malignancy or inborn errors of immunity;Journal of Infection and Chemotherapy;2024-06

2. Designing Potential Anti-Alzheimer's Agents: Template Synthesis, Structural and Theoretical Studies, and Biological Evaluation of a Nickel(Ii) Complex with an N4-Tetradentate 1,2,4-Triazole-Derived Ligand;2024

3. CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults;Clinical Pharmacokinetics;2023-07-28

4. Nanotechnology-Based Approaches for Voriconazole Delivery Applied to Invasive Fungal Infections;Pharmaceutics;2023-01-12

5. Clinical Practice Guideline for the Therapeutic Drug Monitoring of Voriconazole in Non-Asian and Asian Adult Patients: Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring;Clinical Therapeutics;2022-12